Glaucoma Awareness

Noveome Biotherapeutics announces results of Phase 1 trial evaluating glaucoma treatment candidate

According to preliminary results, intranasally delivered ST266 is a safe treatment option.

Now available: First issue of the 2021 Video Journal of Cataract, Refractive, & Glaucoma Surgery

George Waring IV, MD serves as guest host for ‘History and Evolution of Contemporary Refractive Surgery’

Mont Blanc Phase 3 glaucoma trial reaches 50% enrollment milestone

A clinical trial of NCX 470 will evaluate the drug for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension.